Skip to main content
# Title Department Research Year
51 Phytoconstituent Isolation and Cytotoxicity Evaluation of the Egyptian Cassia occidentalis L. Possessing Selective Activity against Lung Carcinoma Department of Pharmacognosy 2023
52 Novel fluoroquinolone hybrids as dual DNA gyrase and urease inhibitors with potential antibacterial activity: Design, synthesis, and biological evaluation Department of Pharmaceutical Organic Chemistry 2023
53 New 1,2,3-Triazole/1,2,4-triazole Hybrids as Aromatase Inhibitors: Design, Synthesis, and Apoptotic Antiproliferative Activity Department of Pharmaceutical Organic Chemistry 2023
54 Chitosan-capped silver nanoparticles with potent and selective intrinsic activity against the breast cancer cells Department of Industrial Pharmacy 2023
55 Thiadiazine-2-thione derivatives as new cell- cycle inhibitors Department of Medicinal Chemistry 2023
56 Phytochemical Investigation, In silico/In vivo Analgesic, and Anti-inflammatory Assessment of the Egyptian Cassia occidentalis L. Department of Pharmacognosy 2023
57 LIPID NANOPARTICLES TECHNOLOGY IN VACCINES; SHAPING THE FUTURE OF PROPHYLACTIC MEDICINE Department of Industrial Pharmacy 2023
58 Tailoring of novel azithromycin loaded zinc oxide nanoparticles for wound healing Department of Microbiology and Immunology 2022
59 Phytochemical investigation, molecular docking studies and DFT calculations on the antidiabetic and cytotoxic activities of Gmelina philippensis CHAM. Department of Medicinal Chemistry 2022
60 Discovery of new pyrimido [5, 4-c] quinolines as potential antiproliferative agents with multitarget actions: Rapid synthesis, docking, and ADME studies Department of Pharmaceutical Organic Chemistry 2022